Madrigal Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -123.3% | -123.3% | -88.5% |
| FY2022 | -149.6% | -119.7% | -81.5% |
| FY2023 | -92.2% | -71.7% | -58.3% |
| FY2024 | -61.8% | -53.4% | -44.7% |
| FY2025 | -47.8% | -30.6% | -22.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -123.3% | -123.3% | -88.5% |
| FY2022 | -149.6% | -119.7% | -81.5% |
| FY2023 | -92.2% | -71.7% | -58.3% |
| FY2024 | -61.8% | -53.4% | -44.7% |
| FY2025 | -47.8% | -30.6% | -22.9% |